NOV 22, 2020 11:20 AM PST

Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD

WRITTEN BY: Annie Lennon

Researchers from St. Michael’s Hospital in Toronto have found that two synthetic cannabinoids available on prescription are linked to an increased risk of death and hospitalization in older patients with chronic obstructive pulmonary disease (COPD). 

For the study, the researchers looked at data from over 4,000 people with COPD in Ontario aged over 66 between 2006 and 2016. The patients were divided into two groups. One group used dronabinol or nabilone, synthetic cannabinoids with a similar chemical structure to THC often prescribed to treat COPD symptoms such as pain, difficulties falling asleep, and breathlessness. Meanwhile, the other group did not use these cannabinoids. 

In the end, the researchers found that while patients who used either cannabinoid were no more likely to be hospitalized for COPD or pneumonia than those in the other group, they were more likely to die of any cause. This was especially true for those who received high doses. All in all, these patients were 178% more likely to be hospitalized for COPD and pneumonia and 231% more likely to die of any cause. 

“Our study results do not mean that cannabinoid drugs should be never used among older adults with COPD,” says Dr. Nicholas Vozoris, lead author of the study. “Rather, our findings should be incorporated by patients and physicians into prescribing decision-making.”

While the researchers say that their findings show a negative association between older adults with COPD and synthetic cannabinoids, further research is needed to confirm their results. Nevertheless, as older adults are increasingly using cannabinoid-based drugs to treat COPD, the researchers say care should be taken when prescribing the drugs and for patients and physicians alike to have a clear understanding of their potential side effects. 

 

Sources: BMJMarijuana Business Daily

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
AUG 14, 2020
Health & Medicine
Does Legalization of Cannabis Mean Users Actually Use Legal Sources?
AUG 14, 2020
Does Legalization of Cannabis Mean Users Actually Use Legal Sources?
Recent research from states that have legalized recreational cannabis, looked at whether users find the drug  is mo ...
AUG 16, 2020
Cannabis Sciences
Cannabinoids May Interact with Prescribed Medications
AUG 16, 2020
Cannabinoids May Interact with Prescribed Medications
Despite the growing popularity of cannabis products, information is currently limited on how they may interact with othe ...
SEP 01, 2020
Plants & Animals
Warsaw Zoo Testing CBD to Manage Elephants' Stress
SEP 01, 2020
Warsaw Zoo Testing CBD to Manage Elephants' Stress
Humans use cannabidiol (CBD) for its array of health benefits, and household pets even benefit from CBD treatments in sp ...
OCT 03, 2020
Cannabis Sciences
Cannabis Compound Prevents Colon Cancer in Mice
OCT 03, 2020
Cannabis Compound Prevents Colon Cancer in Mice
Second only to skin cancer, colon cancer is the most common cancer diagnosed in both men and women in the US. Now, resea ...
OCT 21, 2020
Cannabis Sciences
Exercise Reverses Learning Impairments from Cannabinoid Issues
OCT 21, 2020
Exercise Reverses Learning Impairments from Cannabinoid Issues
While cannabinoids usually get attention for their recreational effects, these molecules play a role in several other pr ...
NOV 05, 2020
Health & Medicine
Medical Cannabis Reduces Chronic Pain and Opioid Use
NOV 05, 2020
Medical Cannabis Reduces Chronic Pain and Opioid Use
Researchers affiliated with the University of Haifa in Israel have reported on the efficacy of medical cannabis use for ...
Loading Comments...